Rojkjaer Lisa 4
4 · RIGEL PHARMACEUTICALS INC · Filed Mar 29, 2024
Insider Transaction Report
Form 4
Rojkjaer Lisa
EVP, Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-03-27+187,500→ 187,500 totalExercise: $1.49Exp: 2034-03-27→ Common Stock (187,500 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to this option vest on March 11, 2025, and 1/48th of the shares subject to this option vest in substantially equal monthly installments over the thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.